StockWatch
·
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Corporate GovernanceJul 16, 2026, 06:07 AM

IRIDEX Board Alleges Stealth Proxy Campaign, Fiduciary Duty Violations

AI Summary

IRIDEX Corporation's Annual Meeting of Stockholders reconvened on July 10, 2026, where all director nominees were elected, BPM LLP was ratified as auditor, and executive compensation was approved. However, the company's board alleges a 'stealth proxy campaign' by its largest stockholder, Novel Inspiration International Co., Ltd., and director William Moore. The board claims this campaign involved violations of fiduciary duties and federal securities laws, causing embarrassment and potential liability, particularly regarding efforts to influence director elections and a proposal to reprice Series B preferred stock conversion.

Key Highlights

  • Annual Meeting reconvened on July 10, 2026, with quorum met.
  • All five director nominees were duly elected to the board.
  • BPM LLP was ratified as the independent auditor for fiscal year 2027.
  • Stockholders approved executive compensation in an advisory vote.
  • Board alleges a 'stealth proxy campaign' by Novel Inspiration and director William Moore.
  • Allegations include violations of fiduciary duties and federal securities law.
  • Board opposed Novel's proposal to reprice Series B conversion due to significant dilution.
  • Board believes the campaign was futile but caused embarrassment and potential liability.